"Grippferon" is an effective and safe medication that is used for the prevention and treatment of acute colds and viral infections, as well as flu. Due to this, it is allowed for the treatment of such pathologies in infants and for pregnant women.
"Grippferon" is an immunomodulatory, antiviral and anti-inflammatory drug for intranasal use.
Description
The main active ingredient of a medical device is a highly active recombinant, that is, produced by genetic engineering, interferon a-2. The medication is absolutely safe with respect to viral contamination, which is extremely important, since in the modern world hepatitis B, C, D are widespread, as well as such dangerous pathologies as HIV, CMV and other infections transmitted through the blood.
The medicine is a clear or light yellow liquid, the shelf life of which is two years. The opened plastic bottle should be stored in the refrigerator at a temperature of up to 8 degrees for no more than one month. Instructions for "Grippferon" are presented below.
pharmachologic effect
The mechanism of action of the main substance contained in this drug is based on eliminating the reproduction of any types of viruses that enter the body by any means, including as a result of respiratory activity.
Already on the second day of using this medication, patients have a significant reduction in the number of viruses eliminated by breathing, and, therefore, the risk of infection of people who come into contact with it is reduced.
Unlike other drugs in this group, it prevents the spread of viruses in the mucous membrane of the nasopharynx, that is, where they first enter the SARS.
This medical product has no direct analogues and surpasses other medicines in the universality of its action on acute respiratory infections:
- It blocks the reproduction of all known types of respiratory viruses that affect humans.
- It has high therapeutic efficacy.
- Effective as a medicine for emergency prevention.
- Not addictive.
Viruses known at the present stage in medical science are not capable of acquiring resistance to the action of the main substance of the Grippferon drug, which is non-toxic and safe. It was found that the drug reduces the frequency of complications in acute respiratory infections by 50-60% and the number of medicines taken by patients by about 60-70%.
It has absolutely no contraindications, and is compatible with any other medications, including a variety of antiviral drugs. "Grippferon" can be used in conjunction with vaccination. This medical product significantly reduces the number of viruses that are secreted from the respiratory tract of patients with acute respiratory viral infections (analogue dressing), and at times reduces the infectivity. It also has very pronounced anti-epidemic properties.
Release form and composition
The release form of "Grippferon" is indicated in the instructions. The drug is available in the form of a metered-dose nasal spray and drops of a light yellow or colorless color. They are packaged in plastic bottles of 5 or 10 ml.
But what is the composition of the preparation "Grippferon"? One dose of the spray contains interferon alfa-2b - at least 500 IU. The auxiliary components are sodium chloride, purified water, povidone, sodium hydrogen phosphate, dodecahydrate, macrogol, disodium edetate dihydrate, potassium dihydrogen phosphate.
1 ml drops contains interferon alfa-2b human recombinant at least 10,000 IU, as well as excipients similar to those in the spray.
Viruses for which the drug is active
To date, science knows more than two thousand serotypes of the influenza virus and more than two hundred varieties of other viruses that cause SARS, each of which may also have hundreds of its subspecies.
During influenza epidemics, only 20% of all infected with this disease specifically. The rest of the people suffer, as a rule, from other respiratory pathological conditions against which vaccination and numerous medications do not protect. Grippferon medication can affect not only the influenza virus, but also other infections that cause respiratory illnesses.
In the course of scientific experimental studies, a pronounced antiviral effect of the drug "Grippferon" on the following types of infections was established:
- All existing strains of the influenza virus, even H1N1.
- Adenovirus AdV 6.
- Human coronavirus HCoV / SPb / 01/03 (229E) - one of the types of this virus causes SARS.
- Respiratory syncytial virus.
- Rubella virus.
- Measles vaccine strain Edmonston.
- The vaccine virus strain mumps L-3.
- Bird flu.
- Parainfluenza virus, strain PG2 / SPb5 / 11/03.
- Lethal strains of bird flu.
Indications
According to the instructions, "Grippferon" is advisable to use for the first symptoms of an acute viral disease, the sooner - the better. This medication is used in the following cases:
- Prevention and treatment of respiratory infections - influenza, rotavirus, colds.
- For the prevention of such diseases.
What is the difference between "Grippferon" for children and adults?
The medication can be used in the treatment of newborns, its use is possible during pregnancy, also for people who, due to weakened immunity, are prone to frequent colds, after contact with people already suffering from SARS and flu, after hypothermia, etc.
The good efficacy of Infantile "Grippferon" was established when using this medicine in preschool. Also among people who are affected by so-called risk factors. These are health workers, teachers, educators, etc. Indications for the use of "Grippferon" are described in the instructions.
Effectively this medication is also for emergency prevention of viral diseases. Unlike vaccines, which create long-term resistance to certain subspecies of the influenza virus, the medication is used directly in cases where there is a real threat of a respiratory infection after close contact with patients, as well as colds, etc.
A single dose of a drug for individual urgent prevention significantly reduces the risk of the onset and development of the disease. In our country, the drug is included in the list of state reserve drugs for cases of bird flu epidemics.
Application and Dosage
As indicated by the instructions for "Grippferon", when the first manifestations of a respiratory disease occur, this drug should be dripped into the nose. Dosages are as follows:
- 1 drop five times a day - for children up to a year.
- 2 drops three times a day - for children from a year to three.
- 2 drops four times a day - at the age of three to 14 years.
- 3 drops every four hours - for adults.
For preventive purposes, the drug is used according to age dosages 2 times a day immediately after contact with the patient. Preventive therapy lasts several days and can be repeated if necessary.
After instillation, the nose should be massaged with a flick of the fingers for several minutes. This is done so that the medicine is evenly distributed on the nasal mucosa.
When using the "Grippferon" drug, there is no need to use vasoconstrictive therapy at the same time, since it relieves swelling of the mucosa and facilitates breathing.
Analogs
"Grippferon" has several analogues, which are medications based on interferons. These drugs include:
- Alpharon.
- Interferon
- Viferon.
- Kipferon.
- Cycloferon.
The remaining funds that are currently available on the pharmacological market are not similar in composition to the medicines, however, they are analogues of Grippferon in the antiviral direction of action. These include:
- Ingavirin.
- "Tsitovir."
- Amiksin.
- "Peramivir".
- Ingavirin.
- Rebetol.
- Lavomax.
- Kagocel.
- Tamiflu.
- "Ribavirin."
- Arbidol.
- "Remantadine."
- Relenza.
special instructions
In accordance with the instructions to "Grippferon", treatment when detecting the first signs of the disease leads to a significant weakening of them. This refers to a runny nose, cough, headache, fever, hyperemia of the mucosa, etc.
The duration of pathological conditions is reduced by 50%. In uncomplicated cases, this medication, as a rule, does not require additional symptomatic therapy with aspirin, sulfonamides, vasoconstrictor drops in the nose. When the temperature rises, the medication “Grippferon” can be combined with various antipyretic drugs.
The use of this medication several times reduces the risk of developing complications such as acute bronchitis, sinusitis, pneumonia, etc. The use of the medicine for prophylactic purposes, during epidemics in children's and medical groups, reduces the risk of morbidity by almost three times. This is especially true for pregnant women. About "Grippferon" there are a large number of reviews.
Reviews
The opinion of consumers about this medication is extremely positive. People who used it for the treatment and prevention of acute respiratory viral infections, note that the tool effectively helps with the first symptoms of such diseases, and it can be used during pregnancy and lactation, which is also a big plus that distinguishes this medication from many others.